{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:43:57Z","timestamp":1789587837282,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100002300","name":"Marsha Rivkin Center for Ovarian Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13048-016-0281-4","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T06:31:59Z","timestamp":1478154719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Synuclein-\u03b3 (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease"],"prefix":"10.1186","volume":"9","author":[{"given":"Anna","family":"Strohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Akers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiam","family":"Bshara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Buttin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene B.","family":"Helenowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunle","family":"Odunsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian C.","family":"Schink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Scholtens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Julie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"issue":"9951","key":"281_CR1","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014;384(9951):1376\u201388.","journal-title":"Lancet"},{"key":"281_CR2","volume-title":"National Cancer Institute","author":"NNA Howlader","year":"2016","unstructured":"Howlader NNA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975\u20132013. In: National Cancer Institute. 2016."},{"issue":"4","key":"281_CR3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0889-8588(03)00056-X","volume":"17","author":"SV Nicosia","year":"2003","unstructured":"Nicosia SV, Bai W, Cheng JQ, Coppola D, Kruk PA. Oncogenic pathways implicated in ovarian epithelial cancer. Hematol Oncol Clin North Am. 2003;17(4):927\u201343.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"281_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1517\/14728222.12.1.59","volume":"12","author":"VK Singh","year":"2008","unstructured":"Singh VK, Jia Z. Targeting synuclein-gamma to counteract drug resistance in cancer. Expert Opin Ther Targets. 2008;12(1):59\u201368.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"281_CR5","first-page":"REVIEWS3002","volume":"3","author":"JM George","year":"2002","unstructured":"George JM. The synucleins. Genome Biol. 2002;3(1):REVIEWS3002.","journal-title":"Genome Biol"},{"issue":"9","key":"281_CR6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1101\/gr.8.9.871","volume":"8","author":"C Lavedan","year":"1998","unstructured":"Lavedan C. The synuclein family. Genome Res. 1998;8(9):871\u201380.","journal-title":"Genome Res"},{"issue":"1","key":"281_CR7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0925-4439(00)00036-3","volume":"1502","author":"A Iwai","year":"2000","unstructured":"Iwai A. Properties of NACP\/alpha-synuclein and its role in Alzheimer\u2019s disease. Biochim Biophys Acta. 2000;1502(1):95\u2013109.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"281_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00441-004-0921-7","volume":"318","author":"O Bohlen Und Halbach von","year":"2004","unstructured":"von Bohlen Und Halbach O. Synucleins and their relationship to Parkinson\u2019s disease. Cell Tissue Res. 2004;318(1):163\u201374.","journal-title":"Cell Tissue Res"},{"issue":"4","key":"281_CR9","first-page":"759","volume":"57","author":"H Ji","year":"1997","unstructured":"Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C, Shi YE. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res. 1997;57(4):759\u201364.","journal-title":"Cancer Res"},{"issue":"17","key":"281_CR10","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1158\/0008-5472.CAN-05-1089","volume":"65","author":"H Liu","year":"2005","unstructured":"Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C, Wang L, Zhao W, Jiang JD, Liu J. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res. 2005;65(17):7635\u201343.","journal-title":"Cancer Res"},{"issue":"11","key":"281_CR11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/molehr\/gan056","volume":"14","author":"MN Singh","year":"2008","unstructured":"Singh MN, Stringfellow HF, Taylor SE, Ashton KM, Ahmad M, Abdo KR, El-Agnaf OM, Martin-Hirsch PL, Martin FL. Elevated expression of CYP1A1 and gamma-SYNUCLEIN in human ectopic (ovarian) endometriosis compared with eutopic endometrium. Mol Hum Reprod. 2008;14(11):655\u201363.","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"281_CR12","first-page":"742","volume":"59","author":"T Jia","year":"1999","unstructured":"Jia T, Liu YE, Liu J, Shi YE. Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res. 1999;59(3):742\u20137.","journal-title":"Cancer Res"},{"issue":"13","key":"281_CR13","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1096\/fj.07-8379rev","volume":"21","author":"M Ahmad","year":"2007","unstructured":"Ahmad M, Attoub S, Singh MN, Martin FL, El-Agnaf OM. Gamma-synuclein and the progression of cancer. FASEB J. 2007;21(13):3419\u201330.","journal-title":"FASEB J"},{"issue":"9","key":"281_CR14","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9","volume":"88","author":"W Bruening","year":"2000","unstructured":"Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, Godwin AK. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer. 2000;88(9):2154\u201363.","journal-title":"Cancer"},{"issue":"Suppl 4","key":"281_CR15","first-page":"53","volume":"59","author":"A Czekierdowski","year":"2008","unstructured":"Czekierdowski A, Czekierdowska S, Danilos J, Czuba B, Sodowski K, Sodowska H, Szymanski M, Kotarski J. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors. J Physiol Pharmacol. 2008;59 Suppl 4:53\u201365.","journal-title":"J Physiol Pharmacol"},{"issue":"3","key":"281_CR16","first-page":"664","volume":"63","author":"A Gupta","year":"2003","unstructured":"Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res. 2003;63(3):664\u201373.","journal-title":"Cancer Res"},{"issue":"4","key":"281_CR17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.9734\/BJMMR\/2011\/769","volume":"1","author":"KT Cheung","year":"2011","unstructured":"Cheung KT, Taylor SE, Patel II, Bentley AJ, Stringfellow HF, Fullwood NJ, Martin-Hirsch PL, Martin FL. Expression of ERalpha, its ERalphaDelta3 Splice Variant and gamma-SYNUCLEIN in Ovarian Cancer: A Pilot Study. Br J Med Med Res. 2011;1(4):430\u201344.","journal-title":"Br J Med Med Res"},{"issue":"1","key":"281_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ijc.26364","volume":"131","author":"T Fekete","year":"2012","unstructured":"Fekete T, Raso E, Pete I, Tegze B, Liko I, Munkacsy G, Sipos N, Rigo Jr J, Gyorffy B. Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples. Int J Cancer. 2012;131(1):95\u2013105.","journal-title":"Int J Cancer"},{"issue":"1","key":"281_CR19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2011.09.037","volume":"124","author":"P Mhawech-Fauceglia","year":"2012","unstructured":"Mhawech-Fauceglia P, Wang D, Syriac S, Godoy H, Dupont N, Liu S, Odunsi K. Synuclein-gamma (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma. Gynecol Oncol. 2012;124(1):148\u201352.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"281_CR20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1349-7006.2004.tb03183.x","volume":"95","author":"H Iwaki","year":"2004","unstructured":"Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, Terai A, Arai Y, Iwamura H, Kawakita M, et al. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci. 2004;95(12):955\u201361.","journal-title":"Cancer Sci"},{"issue":"1","key":"281_CR21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cncr.20321","volume":"101","author":"Z Li","year":"2004","unstructured":"Li Z, Sclabas GM, Peng B, Hess KR, Abbruzzese JL, Evans DB, Chiao PJ. Overexpression of synuclein-gamma in pancreatic adenocarcinoma. Cancer. 2004;101(1):58\u201365.","journal-title":"Cancer"},{"issue":"1","key":"281_CR22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2008.04.037","volume":"269","author":"C Liu","year":"2008","unstructured":"Liu C, Guo J, Qu L, Bing D, Meng L, Wu J, Shou C. Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients. Cancer Lett. 2008;269(1):148\u201358.","journal-title":"Cancer Lett"},{"issue":"22","key":"281_CR23","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1111\/febs.13055","volume":"281","author":"C Liu","year":"2014","unstructured":"Liu C, Qu L, Lian S, Tian Z, Zhao C, Meng L, Shou C. Unconventional secretion of synuclein-gamma promotes tumor cell invasion. FEBS J. 2014;281(22):5159\u201371.","journal-title":"FEBS J"},{"issue":"9","key":"281_CR24","first-page":"920","volume":"12","author":"K Wu","year":"2003","unstructured":"Wu K, Weng Z, Tao Q, Lin G, Wu X, Qian H, Zhang Y, Ding X, Jiang Y, Shi YE. Stage-specific expression of breast cancer-specific gene gamma-synuclein. Cancer Epidemiol Biomarkers Prev. 2003;12(9):920\u20135.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"281_CR25","first-page":"429","volume":"23","author":"Q Ye","year":"2010","unstructured":"Ye Q, Wang TF, Peng YF, Xie J, Feng B, Qiu MY, Li LH, Lu AG, Liu BY, Zheng MH. Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease. Oncol Rep. 2010;23(2):429\u201336.","journal-title":"Oncol Rep"},{"issue":"7353","key":"281_CR26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","unstructured":"Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609\u201315.","journal-title":"Nature"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-016-0281-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T03:30:16Z","timestamp":1568518216000},"score":1,"resource":{"primary":{"URL":"http:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-016-0281-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["281"],"URL":"https:\/\/doi.org\/10.1186\/s13048-016-0281-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]},"article-number":"75"}}